<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02564705</url>
  </required_header>
  <id_info>
    <org_study_id>SPN-14-001</org_study_id>
    <nct_id>NCT02564705</nct_id>
  </id_info>
  <brief_title>Comparative Study of Anterior vs. Posterior Surgical Treatment for Lumbar Isthmic Spondylolisthesis</brief_title>
  <acronym>I-Spondy</acronym>
  <official_title>A Multi-Center, Prospective, Comparative Study of Anterior vs. Posterior Surgical Treatment for Lumbar Isthmic Spondylolisthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AOSpine North America Research Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AOSpine North America Research Network</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare outcomes and cost-effectiveness of anterior versus
      posterior surgical treatment for lumbar Isthmic Spondylolisthesis. The primary objective is
      to compare treatment effectiveness in terms of functional outcomes as measured by Oswestry
      Disability Index (ODI) v2.1a and to compare safety outcomes measured by treatment-related
      adverse events. Secondary objectives are to compare treatments in terms of differences in
      pain, quality of life, health utilities, and need for re-operation. Finally, a
      cost-effectiveness analysis will be performed. This analysis will take the form of
      cost-effectiveness if there is a difference in treatment effects or cost-minimization if
      there is no difference in treatment efficacy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Oswestry Disability Index Score v2.1a</measure>
    <time_frame>between pre-operative and 730 days (24 months)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Numeric Pain Rating Scale (Pain NRS) for low back pain</measure>
    <time_frame>between pre-operative and 730 days (24 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in EQ-5D-3L health utility index</measure>
    <time_frame>between pre-operative and 730 days</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Isthmic Spondylolisthesis</condition>
  <arm_group>
    <arm_group_label>anterior cohort</arm_group_label>
    <description>Anterior Lumbar Interbody Fusion (ALIF)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>posterior cohort</arm_group_label>
    <description>Posterolateral Fusion (PLF)
Posterior Lumbar Interbody Fusion (PLIF)
Transforaminal Lumbar Interbody Fusion (TLIF)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Anterior Lumbar Interbody Fusion (ALIF)</intervention_name>
    <arm_group_label>anterior cohort</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Posterior Fusion</intervention_name>
    <description>Posterolateral Fusion (PLF)
Posterior Lumbar Interbody Fusion (PLIF)
Transforaminal Lumbar Interbody Fusion (TLIF)</description>
    <arm_group_label>posterior cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Isthmic spondylolisthesis (IS)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18 to 80 years, inclusive

          -  Grade I, II or III (less than 75% slip of the cephalad vertebra compared to the caudal
             vertebra) isthmic spondylolisthesis at single level between L4 and S1

          -  Unresponsive to a minimum of 3 months of non-surgical treatment

          -  No previous surgical treatment for isthmic spondylolisthesis

          -  Patients who are medically suitable for surgical management

          -  Patients who have consented for surgical treatment

          -  Willing and able to comply with the Investigational Protocol (IP)

          -  Informed Consent Form (ICF) signed by patient

        Exclusion Criteria:

          -  Any previous lumbar spine surgery

          -  Patient has significant scoliosis (Cobb angle is greater than 25 degrees)

          -  Subject has cauda equina syndrome defined as neural compression causing neurogenic
             bowel (rectal incontinence) or bladder (bladder retention or incontinence) dysfunction

          -  Subject is pregnant or of child-bearing potential and not currently on adequate birth
             control method

          -  Active infection at the surgical site

          -  Recent history (less than 1 year) of chemical substance dependency or significant
             psychosocial disturbance that may impact the outcome or study participation, in the
             opinion of the Investigator

          -  Pre-existent neurologic or mental disorder which would preclude accurate evaluation
             and follow-up (i.e. Alzheimer's disease, Parkinson's disease, unstable psychiatric
             disorder with hallucinations and/or delusions or schizophrenia

          -  Participation in another clinical trial of drug or device within the past 30 days that
             could influence the outcomes of this study

          -  Is a prisoner

          -  Acquired immune deficiency syndrome (AIDS) or AIDS-related complex

          -  Active malignancy or history of invasive malignancy within the last five years, with
             the exception of superficial basal cell carcinoma or squamous cell carcinoma of the
             skin that has been definitely treated; patients with carcinoma in situ of the uterine
             cervix treated definitely more than 1 year prior to enrollment may enter the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Paul Arnold, MD</last_name>
    <phone>(913) 588-7587</phone>
    <email>parnold@kumc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Branko Kopjar, MD PhD</last_name>
    <phone>(206) 607-6861</phone>
    <email>branko.kopjar@nor-consult.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143-0122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Kansas University Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Arnold, MD</last_name>
      <phone>913-558-7587</phone>
      <email>parnold@kumc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Linda Jianas</last_name>
      <phone>(913) 558-3252</phone>
      <email>ljianas@kumc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Paul Arnold, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Ludwig, MD</last_name>
      <phone>410-328-8808</phone>
      <email>sludwig@umoa.umm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Alysa Nash</last_name>
      <phone>(410) 328-8808</phone>
      <email>ANash@umoa.umm.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Steven Ludwig, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Sciubba, MD</last_name>
      <phone>410-955-4424</phone>
      <email>dsciubb1@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Zach Pennington</last_name>
      <phone>(410) 995-4424</phone>
      <email>zpennin1@jhmi.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Daniel Sciubba, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Missouri</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>W. Zack Ray, MD</last_name>
      <phone>314-362-9959</phone>
      <email>rayz@wudosis.wustl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Aubrey Wright</last_name>
      <phone>314-362-3114</phone>
      <email>wrightau@wudosis.wustl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>W. Zack Ray, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University / Rothman Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander R. Vaccaro, MD, PhD</last_name>
      <phone>267-339-3578</phone>
      <email>Alex.Vaccaro@rothmaninstitute.com</email>
    </contact>
    <contact_backup>
      <last_name>Shoshana Fishbein</last_name>
      <phone>(484) 433-7878</phone>
      <email>Shoshana.Fishbein@rothmaninstitute.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Harrop, MD</last_name>
      <phone>215-955-7000</phone>
      <email>james.harrop@jefferson.edu</email>
    </contact>
    <contact_backup>
      <last_name>Maria Patino</last_name>
      <phone>(215) 955-2245</phone>
      <email>maria.patino@jefferson.edu</email>
    </contact_backup>
    <investigator>
      <last_name>James Harrop, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah Department of Orthopedics</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Darrel Brodke, MD</last_name>
      <phone>801-587-5450</phone>
      <email>darrel.brodke@hsc.utah.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ashley Neese</last_name>
      <phone>(801) 587-5430</phone>
      <email>Ashley.Neese@hsc.utah.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Darrel Brodke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia Department of Neurosurgery</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Shaffrey, MD</last_name>
      <phone>434-243-9728</phone>
      <email>CIS8Z@hscmail.mcc.virginia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Judy Beenhakker</last_name>
      <phone>(434) 982-1856</phone>
      <email>jgb3p@virginia.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Christopher Shaffrey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jens Chapman, MD</last_name>
      <phone>206-731-3466</phone>
      <email>Jens.Chapman@swedish.org</email>
    </contact>
    <contact_backup>
      <last_name>Cheryl Kelly</last_name>
      <phone>(206) 320-2334</phone>
      <email>cheryl.kelly@swedish.org</email>
    </contact_backup>
    <investigator>
      <last_name>Jens Chapman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Toronto Western Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Fehlings, MD, PhD</last_name>
      <phone>(416) 603-5627</phone>
      <email>Michael.Fehlings@uhn.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Yuriy Petrenko</last_name>
      <phone>(416) 603-5285</phone>
      <email>yuriy.petrenko@uhn.on.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Fehlings, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 29, 2015</study_first_submitted>
  <study_first_submitted_qc>September 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2015</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylolisthesis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

